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JAILS AND PRISONS - RESERVOIRS OF TB
DISEASE: SHOULD DEFENDANTS WITH HIV
INFECTION (WHO CANNOT SWIM) BE
THROWN INTO THE RESERVOIR?
Faith Colangelo* and Mariana Hogan**
I. Introduction
It is not surprising that the resurgence of tuberculosis (TB) in ur-
ban areas has direct and alarming consequences within the criminal
justice system. Lock-up facilities, jails and prisons are TB breeding
grounds.' It has been well established that TB strikes in populations
that are minority, poor, homeless or living in overcrowded and/or
unsanitary conditions. TB strikes with equal vengeance in popula-
tions with physical vulnerabilities caused by alcoholism, drug addic-
tion, malnutrition, Human Immunodeficiency Virus/Acquired
Immune Deficiency Syndrome (HIV/AIDS) and other immune-sup-
pressing conditions. These are the same populations that are over-
represented in the criminal justice system.2
Between 1980 and 1990 the number of reported cases of TB in New
* Private practitioner specializing in criminal defense in federal district courts; for-
merly Associate Professor of Law, Pace University School of Law; B.A. Boston Univer-
sity, 1968; J.D. Brooklyn Law School, 1974.
** Adjunct Professor, New York Law School; A.B., Brown University, 1976; J.D.,
Georgetown University, 1979.
1. M. Miles Braun et al., Increasing Incidence of Tuberculosis in a Prison Inmate
Population, 261 JAMA 393 (1989); THE NEW YORK CITY TASK FORCE ON TUBERCU-
LOSIS IN THE CRIMINAL JUSTICE SYSTEM, FINAL REPORT 11-12 (1992) [hereinafter RE-
PORT ON TB IN THE CRIMINAL JUSTICE SYSTEM]. See also, Tuberculosis: Hearings
before the Subcomm. on Human Resources and Intergovernmental Relations of the Gov-
ernment Operations Comm., 101st Cong., 2nd Sess. 5 (1991) (testimony of Dr. Margaret
A. Hamburg).
2. REPORT ON TB IN THE CRIMINAL JUSTICE SYSTEM, supra note 1 at 11-12.
Tuberculosis is a disease of poverty, social alienation, crowding, and home-
lessness. The epidemic will not abate until increasing proportions of the popu-
lation have sufficient income to live decently and receive sufficient education to
support themselves in our communities. HIV infection in New York occurs
predominantly among drug using people. Drug use is preventable, drug treat-
ment can be effective, and prisons are an expensive distraction in the march
against drug use; too expensive for our society, where the costs of incarceration
are high in human terms, in addition to fiscal.
TB Behind Bars: Hearings Before the Joint Assembly Committees on Correction and
Health, 214th Gen. Assembly, 2d Reg. Sess. 2 (N.Y. 1992) (testimony of Robert Greif-
inger, M.D.).
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York City rose 135%. The incidence of TB in urban areas is further
magnified in the criminal justice system, particularly in holding pens,
lock-ups, prisons and jails.4 The Centers for Disease Control estimate
that TB cases occur at least three times more often in correctional
settings than in the general population; in larger correctional systems
the incidence rate may be as much as six to eleven times the normal
rate.5 This trend is most alarming when coupled with the HIV
epidemic.
People with HIV are particularly susceptible to contracting TB be-
cause they lack a healthy immune system.6 To further complicate
matters, some newer strains of TB are resistant to many conventional
drug treatments. These multiple-drug resistant tuberculosis (MDR
TB) strains are also prevalent in correctional systems.7 The threat of
MDR TB is particularly alarming for persons with HIV infection.
More than 90% of those who recently developed active MDR TB
disease in four of the New York City hospitals studied were HIV-
infected, and more than 80% of those persons died within four to
sixteen weeks of their TB diagnosis.8
The confluence of the HIV epidemic, the resurgence of TB and the
appearance of MDR TB present unsurmountable problems for the
criminal justice system.9 This Essay focuses on the problem: Is justice
3. REPORT ON TB IN THE CRIMINAL JUSTICE SYSTEM, supra note 1, at 10.
4. REPORT ON TB IN THE CRIMINAL JUSTICE SYSTEM, supra note 1, at 11-12.
The alarmingly high TB prevalence in New York City's correctional system is
due to the over-representation in the criminal justice system of populations at.
high risk for contracting TB: individuals who are infected with HIV, substance -
abusers, individuals with poor health status, inadequate housing or who are
homeless. In addition, environmental conditions that facilitate the spread of TB
are endemic throughout the system-crowding in jails, congregate housing and
holding areas; poor ventilation; and rapid movement.
Id.
5. CENTERS FOR DISEASE CONTROL, U.S. DEP'T OF HEALTH & HUMAN SERV.,
CONTROL OF TUBERCULOSIS IN CORRECTIONAL FACILITIES A GUIDE FOR HEALTH
CARE WORKERS [hereinafter CONTROL OF TB IN CORRECTIONAL FACILITIES].
6. Charles L. Daley, M.D. et al., An Outbreak of Tuberculosis with Accelerated Pro-
gression Among Persons Infected with the Human Immunodeficiency Virus, 326 NEW
ENG. J. MED. 231 (1992).
7. See generally, WILLIAM GAUNAY, NEW YORK STATE COMM'N OF CORRECTION,
AN OUTBREAK OF MULTIPLE DRUG RESISTANT TUBERCULOSIS AMONG NEW YORK
STATE CORRECTIONAL FACILITY INMATES (1992) [hereinafter GAUNAY, MDR TB
OUTBREAK REPORT AMONG INMATES].
8. Nosocomial Transmission of Multidrug-Resistant Tuberculosis Among HIV-In-
fected Persons - Florida and New York 1988-1991, 40 MORBIDITY & MORTALITY
WKLY. REP. 585-87 (1991) [hereinafter MDR TB Among HIV Infected in Florida and
New York].
9. Elisabeth Rosenthal, Doctors Warn ofLooming TB Threat, N.Y. TIMES, Nov. 16,
1991, at A22. "The spread of the disease (MDR-TB) 'will be devastating,' said Dr.
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served by sentencing a person with a compromised immune system to
a term of incarceration where there is a significant risk of exposing the
defendant to a deadly disease?
Many factors lead to the conclusion that alternatives to incarcera-
tion are necessary for certain individuals with HIV infection. These
include: (1) the difficulties of detection and treatment of TB and
MDR TB in HIV-infected individuals; (2) the physical conditions that
facilitate transmission of TB in prison; (3) the overrepresentation in
prisons of people with high risk factors for HIV infection and their
particular susceptibility to TB;' 0 (4) the burgeoning costs of TB treat-
ment in prisons; and (5) the deadly effects of the disease in persons
with HIV-immunosuppression.
Plea bargaining and sentencing restrictions in the New York State
Penal Law 1 and Criminal Procedure Law 12 limit the alternatives
judges, prosecutors and defense attorneys have in fashioning appro-
priate dispositions for people who are terminally ill or at high risk for
contracting a terminal illness in prison. The result is that a portion of
the defendants who would otherwise be appropriately sentenced to
alternatives to incarceration (thus allowing them to get medical care
that is infinitely less costly, in a nonincarcerative setting)13 are sen-
tenced to prison.
It is time for New York State to reevaluate the mandatory sentenc-
Michael Iseman of the National Jewish Center for Immunology and Infectious Diseases,
the country's leading experts [sic] on resistant TB. 'We'll see lethal outcomes and mas-
sive epidemics - particularly in shelters, hospitals, AIDS hospices and prisons. It has all
the makings of a tragedy.' " Id.
There are many civil cases pending where courts have recognized the particular dan-
gers of the TB epidemic in institutional settings: Mixon v. Grinker, 556 N.Y.S.2d 855
(App. Div. 1990) (suit brought by homeless persons with HIV illness for the right to safe
housing outside TB infested shelters); Vega v. Sielaff, No. 92 Civ. 6475, 1992 U.S. Dist.
LEXIS 5249 (S.D.N.Y. Apr. 22, 1992) (suit that has resulted in construction of a court
ordered Contagious Disease Unit on Rikers Island in response to TB contagion); Grubbs
v. Brown, No. 92 Civ. 2132 (S.D.N.Y.) (suit brought by pre-arraignment detainees for the
unhealthy, inhumane, degrading and unequal conditions of confinement in police pre-
cincts, booking facilities, and courthouse pens); Austin v. Pennsylvania Dep't of Correc-
tions, Civ. No. 90-7497, 1992 U.S. Dist. LEXIS 14971 (E.D. Pa. Sept. 29, 1992)
(injunction ordering the Pennsylvania Department of Corrections to develop and imple-
ment better control and treatment measures to decrease inmates' imminent risk of TB
infection). While we applaud improvement of the conditions that contribute to the TB
epidemic the medical evidence and the sociological context of prisons make eradication of
TB risks impossible.
10. Daley, supra note 6, at 231.
11. N.Y. PENAL LAW § 70 (McKinney 1987).
12. N.Y. CRIM. PROC. LAW § 220.10 (McKinney 1992).
13. Telephone Interview with Robert Greifinger, M.D., Deputy Commissioner, Chief
Medical Officer, New York State Department of Correctional Services (October 10,
1992). According to Dr. Greifinger, the following are rough estimates of inmate hospitali-
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ing laws and restrictions on plea bargaining. The interaction of HIV
disease and TB offers a striking example of why justice is not served
by binding the judiciary's hands.
Part II of this Essay provides a medical overview of HIV infection
and TB and their ominous interaction. It outlines the scope and impli-
cations of these two epidemics for criminal defendants entering the
prison system. Part III of this Essay discusses the legal limitations
facing judges and practitioners who are trying to justly adjudicate
criminal cases in New York State, and offers strategies for maximiz-
ing the flexibility of a flawed system.
II. Medical Overview
A. Stages of HIV Illness
HIV is a virus that attacks and progressively damages the human
body's immune system. This gradual destruction is usually marked
by steady reduction of an important lymphocyte cell, the CD4+ T-
lymphocyte.14 These cells normally prevent infectious diseases from
taking hold by stimulating the blood system's cellular defenses. 5 As
zation costs in New York State prisons. These costs do not include drug therapy costs at
the institution or screening and follow-up costs at each facility.
Inmate hospitalizations are divided into those occurring in secured wards and those in
unsecured wards. The estimates that follow are predicated on the following assumptions:
1. One "bed day" equals the cost of one hospital bed used for a. twenty-four hour
period.
2. A "secured ward" is a prison ward in a hospital.
3. An "unsecured ward" is a regular hospital ward where security guards must keep
guard and there are no special locks for securing inmates/patients.
4. 40% of the hospitalizations in New York State Department of Correctional Serv-
ices are in unsecured hospital wards.
5. A security officer's salary is $39,600 base salary including benefits, the hourly rate
for an officer is at a minimum, $20.00.
A secured ward hospitalization of an inmate would cost The Department of Correc-
tional Services $1,500 per day. ($1,000 per day for the hospital bed and $500 per day for
one security officer per patient per day). An unsecured ward needs two security officers,
therefore $2,000 per day.
A person in custody is not entitled to 50% Federal reimbursement under Medicaid.
New York State pays 100% of an inmate's health costs.
A hospitalization for a patient with TB disease is roughly 14 to 30 days. Each inmate
who develops active TB while incarcerated and who needs to be hospitalized costs the
State of New York between $21,000 and $60,000.
A similarly situated person on public assistance in the community would cost the State
and City roughly $7,000 to $15,000 in hospital costs.
Assuming 150 inmates need hospitalization for TB treatment in 1992 the cost to New
York State ranges from a low of $3,150,000. to a high of $9 million.
14. C. EVERETT Koop, SURGEON GENERAL'S REPORT ON ACQUIRED IMMUNE DE-
FICIENCY SYNDROME 1, 10, 26 (1986).
15. Id.
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the immune system is progressively destroyed the body becomes in-
creasingly vulnerable to a variety of infections it once could defend
against. 16
Once infected with HIV, a person will usually have no symptoms
for several years. While the virus is taking hold, but before it has de-
stroyed the immune system, a variety of symptoms begin to develop:
night sweats and prolonged fevers, severe diarrhea, weight loss and
fatigue. At this stage the person is vulnerable to a variety of infec-
tions, including bacterial pneumonias, cervical cancer and pulmonary
tuberculosis.17 These infections have serious and often fatal conse-
quences to those who are HIV-infected. s
If a person with HIV infection evades or overcomes the more com-
mon bacterial infections the illness will progress until an "opportunis-
tic" infection such as Kaposi's sarcoma or pneumocystis carinii
pneumonia (pcp) develops. Once a person with HIV infection gets an
"opportunistic" infection, a diagnosis of full blown AIDS can be
made. Many people with HIV die before they ever get an "AIDS"
diagnosis. 19
Because of the high prevalence of certain more common illnesses in
HIV-infected persons, and the severe medical consequences of these
combinations, the Centers for Disease Control have proposed adding
pulmonary TB, cervical cancer and recurrent bacterial pneumonia to
the list of "indicator" illnesses defining AIDS.2 °
The length of time from infection until the onset of symptoms is
highly variable, and depends on such factors as an individual's overall
health, diet and access to medical care. Additionally, the life expec-
tancy of an HIV-infected individual is affected by a number of vari-
ables, including, race, age, medication and whether one is
incarcerated or living in the community.
16. Human Immunodeficiency Infection in the United States, 36 MORBIDITY & MOR-
TALITY WKLY. REP. 801 (1987).
17. CENTERS FOR DISEASE CONTROL, U.S. DEP'T OF HEALTH & HUMAN SERV.
ADDENDUM TO THE PROPOSED EXPANSION OF THE AIDS SURVEILLANCE CASE DEFI-
NITION 2 (1992) [hereinafter ADDENDUM TO THE PROPOSED EXPANSION OF THE AIDS
SURVEILLANCE CASE DEFINITION].
18. Id. See also, JOINT SUBCOMM. ON AIDS IN THE CRIMINAL JUSTICE SYSTEM,
ASSOCIATION OF THE BAR OF THE CITY OF NEW YORK, AIDS IN THE CRIMINAL JUS-
TICE SYSTEM: FINAL REPORT AND RECOMMENDATIONS 14 (1989) [hereinafter NYC
BAR ASS'N AIDS REPORT].
19. NYC BAR ASS'N AIDS REPORT, supra note 18, at 20-21.
20. Letter from James W. Curran, M.D., M.P.W., Assistant Surgeon General, U.S.
Dep't of Health & Human Serv. to Public Health Officials (Oct. 23, 1992) (on file with
author); ADDENDUM TO THE PROPOSED EXPANSION OF THE AIDS SURVEILLANCE
CASE DEFINITION, supra note 17, at 4, 5, 7.
1993]
FORDHAM URBAN LAW JOURNAL
B. Tuberculosis2 - The Difference Between Latent Tuberculosis
Infection and Active Tuberculosis Disease
Pulmonary TB is caused by a bacterium, mycobacterium tuberculo-
sis, that lodges in the lungs.22 If the bacterium is not controlled by
medication or the body's immune system, it breeds, causing active TB
disease. The tubercle bacilli multiply and kill lung tissue, causing un-
controllable coughing, fevers, and eventually death.23
TB is transmitted when a person with active, contagious TB disease
coughs the bacilli into the air and the air is inhaled by another person.
The bacteria multiply in the lungs for a short time before a healthy
body's defenses surround and contain it. The bacilli may remain set-
tled in the lungs in a dormant state for weeks, months or years. This
condition of latent TB bacilli in the lung is termed TB infection. The
healthy person with latent TB infection will probably always test
"positive" for TB24 but will usually not become sick, develop any
symptoms of active TB, or be contagious.2"
TB disease is a highly communicable,26 opportunistic disease which
21. For purposes of this Essay from this point on when we refer to tuberculosis we are
referring to pulmonary tuberculosis.
22. CONTROL OF TB IN CORRECTIONAL FACILITIES, supra note 5, at 3-4.
23. Elisabeth Rosenthal, Doctors and Patients Are Pushed to Their Limits by Grim
New TB, N.Y. TIMES, Oct. 12, 1992, at Al, B2.
24. See Samuel W. Dooley, Jr. et al., Guidelines for Preventing the Transmission of
Tuberculosis in Health-Care Settings, with Special Focus on HIV-Related Issues, 39 MOR-
BIDITY & MORTALITY WKLY. REP. 5 (1990) [hereinafter Preventing TB in Health-Care
Settings]. The skin test for latent tuberculosis infection that is referred to throughout this
Essay is called the "Mantoux skin test" and the "PPD test." It is defined as follows:
Tuberculin skin test. The Mantoux technique (intradermal injection of 0.1 ml
of purified protein derivative (PPD) containing 5 tuberculin units (TU) should
be used as a diagnostic aid to detect tuberculous infection. Although tuberculin
skin tests are < 100% sensitive and specific for detection of infection with M.
tuberculosis, no better diagnostic method has been devised. Tuberculin skin
tests should be interpreted according to current guidelines (footnotes omitted).
for persons with HIV infection, a reaction of > 5 mm is considered positive.
Id.
25. CONTROL OF TB IN CORRECTIONAL FACILITIES, supra note 5, at 4. "A person
who has TB infection without disease: cannot spread infection to others; is not considered
a case of TB; usually has a negative chest x-ray and no symptoms of TB; but DOES have
TB bacteria in his or her body that remain capable of causing disease at any time later in
life." Id. Usually the only evidence of TB infection is a positive reaction to the Mantoux
tuberculin skin test.
26. Preventing TB in Health-Care Settings, supra note 24, at 3. M. tuberculosis, a ba-
cilli, is carried in airborne particles, known as droplet nuclei, that can be generated when
persons with pulmonary or laryngeal tuberculosis disease sneeze, cough, speak or sing.
The TB bacilli, Mycobacterium tuberculosis, can infect any part of the body. People that
are most capable of spreading the disease are those with pulmonary, laryngeal tuberculo-
sis disease and those with TB disease in the respiratory tract or oral cavity. Infection is
caused primarily by breathing in the droplet nuclei. "The [droplet nuclei] particles are so
[Vol. XX
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develops when a TB-infected individual's health breaks down and the
once latent TB bacteria activate and grow. 27 For a small proportion
(3% to 5%) of newly infected persons initial infection progresses to
TB disease (progressive primary disease) within a year. Another 3%
to 5% group will develop TB disease at some point in their life when
the once contained and latent bacteria begin to replicate and produce
disease (reactivation disease).2" However, this is not the clinical pic-
ture for a person with HIV-immunosuppression.
For persons infected with HIV who are exposed to TB or who have
latent TB infection, the statistical profile for developing active, conta-
gious disease is far worse. HIV infection progressively inhibits the
body's ability to ward off TB all together, or to contain it in a latent
state; therefore, a person who is HIV-immunosuppressed is much
more likely to develop active, contagious TB disease and develop it
more rapidly.
In one study of thirty residents of a housing facility for HIV-in-
fected persons exposed to TB, active tuberculosis disease developed in
eleven (37%), and four others (13%) had newly positive tuberculin
skin tests indicating latent TB infection.29 The total duration of the
outbreak was 106 days and in one patient disease developed within
four weeks.30 This study demonstrates that persons with HIV infec-
tion who are initially exposed to TB have a high risk of rapid progres-
sion to active TB disease.
C. HIV Infection Undermines the Effectiveness of Tuberculosis
. Detection, Treatment and Prevention/Infection Control
The three prongs of TB control are detection, treatment and pre-
vention/infection control. The protocols for TB screening and treat-
ment are generally effective for persons with healthy immune systems.
However, for persons with HIV-immunosuppression, the difficulties
in screening for latent TB infection and the inability to diagnose and
treat active, contagious TB disease have become life-threatening. The
added and more frightening consequences of the recent outbreaks of
drug, resistant TB strains has awakened the terror of the original
small (1-5 microns) that normal air currents keep them airborne and can spread them
throughout a room or building." Id. Infection "occurs when a person inhales droplet
nuclei containing M. tuberculosis, and bacilli become established in the alveoli of the
lungs and spread throughout the body." Id. '
27. CONTROL OF TB IN CORRECTIONAL FACILITIES, supra note 5, at 4.
28. Daley, supra note 6, at 235.
29. Id at 234.
30. Id. at 235.
19931
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"white plague" of the early 1900s.31
1. Detection of Latent Tuberculosis Infection
Diagnosing latent TB infection is generally accomplished by a skin
test. The skin test recommended in protocols for screening is the
Mantoux skin test, also know as the PPD test.32 A small amount of
killed tubercle bacilli is injected in the skin usually on the inner fore-
arm. After forty-eight to seventy-two hours, a person with a healthy
immune system who has TB infection will have a reaction, usually
swelling and redness around the injection site. The reaction is then
measured in millimeters.33
Because the test is predicated on the ability of the body to mount an
immune reaction to the dead TB bacilli, the test is not effective in
screening latent TB infection in persons with a compromised immune
system. In HIV-immunosuppressed individuals with latent TB infec-
tion, a failure to react to the PPD test is called "anergy." In addition,
a negative skin test, (small or no reaction) does not rule out latent TB
infection. 34 False-negative results are more likely in an HIV-infected
31. Rorie Sherman, TB Hysteria, Repeated?, NAT. L. J., June 29, 1992, at 1.
When the century was still young and the discovery that tuberculosis was
caught, not inherited, was still new, public health officials launched a crusade to
contain the lethal contagion then known as 'The White Plague.'
The most drastic measures, adopted in New York, Boston and elsewhere,
enabled officials to cart away anyone suspected of having TB, involuntarily and
without judicial hearings, to sanatoriums for indefinite stays.
Id. See also, Sheila M. Rothman, The Sanitorium Experience: Myths and Realities, in
UNITED HOSPITAL FUND OF NEW YORK, A SPECIAL REPORT, THE TUBERCULOSIS
REVIVAL: INDIVIDUAL RIGHTS AND SOCIETAL OBLIGATIONS IN A TIME OF AIDS 67
(1992).
Tuberculosis was the leading cause of death throughout the nineteenth century.
From 1800 to 1850, it accounted for 25 percent of all deaths, and it was a social
leveler, affecting the well-born and renowned as well as the poor. In 1852, for
example, when Franklin Pierce was elected president, his wife Jane probably
had the disease (indeed, almost all her family had succumbed to it), the newly
elected vice president was in Cuba in search of a cure (he was sworn in there but
died before he could assume office), and the secretary of state's son was in the
last stage of the disease.
Id.
32. Preventing TB in Health-Care Settings, supra, note 24, at 5.
33. Id.
34. Peter A. Selwyn, M.D. et al., A Prospective Study of the Risk of Tuberculosis
Among Intravenous Drug Users with Human Immunodeficiency Virus Infection, 320 NEW
ENG. J. MED. 9 (1989). Selwyn suggests that since 27% of his population of HIV-sero-
positive subjects were anergic on multiple-antigen skin testing there may have been some
degree of underdetection of latent tuberculous infection among these subjects. See also
Neil M.H. Graham, M.D. et al., Prevalence of Tuberculin Positivity and Skin Test Anergy
in HIV-1-Seropositive and -Seronegative Intravenous Drug Users, 267 JAMA 369-373
(1992). This study indicates the difficulty in reading PPD test reactions of HIV-infected
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individual and the chances for such false results increase as HIV dis-
ease progresses."
2. Diagnosis of Active, Contagious Tuberculosis Disease
No screening test is available for the early detection of active, con-
tagious TB disease. Chest x-rays in immunologically healthy individ-
uals with TB disease will normally show "cavities" and other
radiological signs to enable a physician to diagnose active, contagious
TB disease.36 In HIV-immunosuppressed individuals these signs are
not usually present and the x-rays are not as predictive of an active,
contagious case of TB disease.37
TB disease diagnosis can only be confirmed by obtaining a bacterio-
logical specimen, usually sputum for an acid fast bacilli "AFB" 38
smear and culture. If the cultured specimen reveals the presence of
Mycobacterium tuberculosis, the active, contagious TB disease diagno-
sis is confirmed.39
Unfortunately, immunocompromised individuals (such as those
with HIV infection) are difficult to screen and test for TB.4 Accord-
ing to doctors at the Centers for Disease Control, "[t]he failure to
diagnose tuberculosis rapidly in HIV-infected persons has led to
persons. The study suggests that using the CDC guideline of an induration of > 5mm in
diameter for PPD TB positivity in HIV-1 seropositives "significantly underestimates the
'true' infection rate ..... Id. at 369.
35. Preventing TB in Health-Care Settings, supra note 24, at 7.
A negative skin test does not rule out tuberculosis disease or infection. Because
of the possibility of a false-negative result, the tuberculin skin test should never
be used to exclude the possibility of active tuberculosis among persons for
whom the diagnosis is being considered, even if reactions to other skin-test
antigens are positive. Persons with HIV infection are more likely to have false-
negative skin tests than are persons without HIV infection (footnotes omitted).
The likelihood of a false-negative skin test increases as the stage of HIV infec-
tion advances (CDC/Florida Department of Health and Rehabilitative Serv-
ices/New York City Department of Health, unpublished data). For this reason,
a history of a positive tuberculin reaction is meaningful, even if the current skin-
test result is negative.
Id. See also, Selwyn, supra note 34, at 549; Graham, supra note 34, at 373.
36. Dixie E. Snider, Jr., M.D. and William L. Roper, M.D., The New Tuberculosis,
326 NEW ENG. J. MED. 703 (1992).
37. Snider and Roper, supra note 36, at 703.
38. "AFB" is Acid-fast bacilli. "They are organisms that retain certain stains, even
after being washed with acid alcohol. Most are mycobacteria. When seen on a stained
smear of sputum or other clinical specimen, a diagnosis of tuberculosis should be consid-
ered." Preventing TB in Health-Care Settings, supra note 24, at 25.
39. CONTROL OF TB IN CORRECTIONAL FACILITIES, supra note 5, at 7.
40. Jordan B. Glaser, Joseph K. Aboujaoude, and Robert Greifinger, Tuberculin Skin
Test Conversion Among HIV-Infected Prison Inmates, 5 J. ACQUIRED IMMUNE DEFI-
CIENCY SYNDROMES 4, 431 (1992).
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higher mortality rates, as well as to the transmission of tuberculosis in
hospitals and other settings."4 Because an HIV-infected person can-
not be quickly and reliably screened for contagious TB disease, the
danger of TB transmission to other inmates and corrections staff is
frighteningly obvious.
3. Multiple Drug-Resistant Tuberculosis (MDR TB)
To further complicate matters, some strains of TB are resistant to
many available drug treatments. In addition to being difficult to diag-
nose and treat, multiple drug-resistant TB strains are expensive to
treat.42 The medical evidence demonstrates that people with HIV ill-
ness are most vulnerable to MDR TB. "About 90% of cases of drug-
resistant tuberculosis have occurred in HIV-infected persons. Mortal-
ity rates from disease of this type range from 70 to 90%, with a me-
dian of four to sixteen weeks from diagnosis to death."43
TB that is incompletely or incorrectly treated yields MDR tuber-
culosis that is even more difficult to treat. The incomplete or insuffi-
cient treatment enable the bacilli to survive by learning to evade each
new medicine until there are few if any drugs that will successfully
control the mutated bacilli.' An individual may also become initially
infected with MDR TB by a resistant strain.45 In a recent study of
466 TB patients in New York City, MDR TB seemed to be acquired
with the initial infection in over 70% of the patients.4 6
In April 1991 the Centers for Disease Control and the New York
City Health Department studied all individuals with a positive culture
for TB and found that 30% of all individuals were resistant to one
41. Snider and Roper, supra note 36, at 704.
42. Michael Specter, Neglected for Years, TB Is Back With Strains That Are Deadlier
- Opportunities to Eradicate the Disease Were Lost, N.Y. TIMES, October 11, 1992, at 1,
44. "Enough medicine to cure a patient of a simple, uncomplicated case of TB costs
$300. With drug-resistant strains those costs rise to more than $6,000. The entire medi-
cal bill for a simple TB case, including the price of drugs, supervised therapy and medical
exams, averages about $11,000, according to the C.D.C. But treating TB resistant to two
or more drugs usually exceeds $250,000." Id. at 44. See also Rosenthal, supra note 23, at
B2. "'There are no protocols for treating MDR TB,' said Dr. Eran Bellin. Dr. Bellin, of
Montefiore Medical Center, who is head of infectious diseases at the Rikers Island correc-
tional center in New York City, notes that 'they do it one way at Columbia. Another at
Cornell. I have my own idiosyncratic mix. We really need cooperative studies to give us
better guidance.'" Id. See generally, Interview with Robert Greifinger, supra note 13.
43. Snider and Roper, supra note 36, at 704.
44. Rosenthal, supra note 23, at Al, B2. See also Fred Ayvazian, M.D., Origins of
Resistance, Letter to the Editor, N.Y. TIMES, Nov. 3, 1992, at A18.
45. Brian R. Edlin, M.D. et al., An Outbreak of Multidrug-Resistant Tuberculosis
Among Hospitalized Patients with the Acquired Immunodeficiency Syndrome, 326 NEW
ENG. J. MED. 1514 (1992).
46. Rosenthal, supra note 23, at B2.
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drug, isoniazid (INH) and 19% were resistant to at least two drugs,
INH and rifampin (RIF).47 Once the arsenal of drugs has been ex-
hausted (some patients take up to twelve pills and one shot daily) the
treatment is surgically aggressive (collapsing or removing an infected
lung) and very costly."
D. Multiple Drug-Resistant Tuberculosis - Difficulty of Initial
Diagnosis
The control of MDR TB is severely hampered by the difficulty in
diagnosis and in early successful treatment. The drugs initially ad-
ministered to the patient following TB diagnosis may not kill resistant
strains of the disease. Cultures must be analyzed separately for drug
susceptibility, as the ineffectiveness of drugs used to treat TB is not
readily apparent without laboratory confirmation of resistance. These
tests "may take three to eight weeks for colony growth and then three
to eight additional weeks for incubation with antimicrobial agents"' 9
while the unsuccessfully treated disease continues to progress and
spread, particularly in HIV-immunosuppressed individuals.5 0
E. Tuberculosis Treatment
Once TB disease is suspected but before confirmation, the patient
usually begins drug therapy and is put in AFB isolation until sputum
tests are clear."1 The entire treatment for TB disease may last from
six to twelve months or longer if the sputum tests continue to be posi-
tive for the bacilli.
There are four main drugs used in the treatment and prevention of
47. REPORT ON TB IN THE CRIMINAL JUSTICE SYSTEM, supra note 1, at 16.
48. Specter, supra note 42. See also, Rosenthal, supra note 23.
49. Edlin, supra note 45, at 1520.
50. Snider and Roper, supra note 36. "The delay in identifying patients with drug-
resistant strains adds to the problem. A recent survey by the Centers for Disease Control
(CDC) found that only 61 percent of all isolates were tested for drug susceptibility (un-
published data), and several weeks are required to obtain the results of drug-susceptibility
tests. Patients with unrecognized drug-resistant disease may be treated with ineffective
regimens and thus continue to transmit infection." Id. at 704. See also, MDR TB Among
HIV Infected in Florida and New York, supra note 8, at 589; GAUNAY, MDR TB OUT-
BREAK REPORT AMONG INMATES, supra note 7, at 3.
51. Acid-fast bacilli (AFB) isolation is used to designate the type of isolation room
required to prevent the transmission of TB from patients with active TB disease to others
by reducing the amount of infectious droplet nuclei in the general air. The room must
have negative air pressure (air only flows into the room) and that there be at least four to
six complete air exchanges in the room per hour, with the exhausted air vented to the
outdoors. CONTROL OF TB IN CORRECTIONAL FACILITIES, supra note 5, at 8. See also,
DIVISION OF HEALTH SERVICES, DEPARTMENT OF CORRECTIONAL SERVICES, DOCS
HEALTH SERVICES POLICY MANUAL - TUBERCULOSIS III(C) 4 (1991).
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tuberculosis: isoniazid (INH), rifampin (RIF), pyrazinamide (PZA),
and ethambutol (EMB).52 The initial phase of treatment for an active
case of TB disease is two months of daily doses of INH/RIF/PZA/
EMB. The second phase of treatment, the continuation phase, re-
quires four months of daily or twice weekly doses of INH/RIF. For
an HIV-positive patient the continuation phase lasts a minimum of
seven months for a total of nine months (minimum) of daily or twice-
weekly pill taking.53
For people who test PPD positive, but who have not progressed to
active TB disease, preventive drug therapy is advised. Preventive
therapy usually consists of six months of INH administered daily or
twice a week. For people who are HIV-infected the recommended
course of preventive therapy is at least twelve months. The drugs are
taken as a prophylaxis to prevent the development of active TB
disease. 4
After several weeks of drug therapy, a TB patient may no longer be
contagious. A series of bacilli-clear sputum tests and a reduction of
symptoms (less coughing, weight gain) usually indicate that the pa-
tient is responding to the medication." Each person must be evalu-
ated individually to determine that they are no longer contagious and
may leave isolation. However, the medication must continue to be
administered even if the sputum tests are clear in order to prevent
relapse and reactivation of the bacilli.- 6
Knowledge of the specific treatment regimens is essential to an un-
derstanding of the difficulties of ensuring that infectious individuals
take their medicine. In addition to the length and complexity of the
treatment, some of the TB drugs have disturbing side effects, e.g. diz-
ziness, constant nausea, and liver toxicity, which may cause patients
to be reluctant to continue taking the drugs. " Failure to complete
the drug therapy has serious public health consequences. If the treat-
ment regimen is inaccurate or incomplete, the TB bacillus is not con-
52. CONTROL OF TB IN CORRECTIONAL FACILITIES, supra note 5, at 9.
53. Id.
54. Id. See also Theresa Jordan, Ph.d. et al., Isoniazid as Preventive Therapy in HIV-
Infected Intravenous Drug Abusers, 265 JAMA 2987, (1991).
55. See CONTROL OF TB IN CORRECTIONAL FACILITIES, supra note 5, at 9.
56. See, The Use of Preventive Therapy for Tuberculous Infection in the United States -
Recommendations of the Advisory Committee for Elimination of Tuberculosis, 39 MOR-
BIDITY & MORTALITY WKLY. REP. 8 (1990).
57. James W. Long, M.D., THE ESSENTIAL GUIDE TO PRESCRIPTION DRUGS 597,
925 (1992). See also, Rosenthal, supra note 23. "The average patient under treatment for
drug-resistant TB must take over a dozen pills and a shot a day. Some of the drugs
produce serious nausea and drowsiness; others alarmingly often lead to hearing loss and
dizziness; another produces personality changes and psychosis." Id. at B2.
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trolled and may mutate to a virile, drug resistant form."8
F. HIV Infection, Tuberculosis and the Prisons
The return of TB is not a fluke or a mystery but the predictable
outcome of a glaring social failure. Over the past decade, home-
lessness, drug abuse and AIDS have left a huge population defense-
less against the germ that causes the disease. By ignoring those
people's medical needs - and crowding thousands of them into pris-
ons, shelters and holding pens - America has essentially cultivated
the contagion. 59
TB transmission is a function of two basic variables: the TB profile
of the population and the physical characteristics of the environment.
The TB profile of the inmate population in the criminal justice system
is the highest by any standard.' ° The environment that is of highest
risk is one that does not permit the dispersal of TB germs, i.e. one that
is crowded, physically antiquated and poorly ventilated. The holding
pens in the police precincts, court houses and jails, as well as most of
the prisons in New York State, qualify as high-risk environments.6 I
The prisons and jails have become a breeding ground for tuberculo-
sis disease. For increasing numbers of the urban, minority poor who
are HIV-infected, the criminal justice system has become a reservoir
of TB disease. 62 As their HIV disease progresses many inmates suc-
cumb to an early death hastened by TB disease. Approximately
58. MDR TB Among HIV Infected in Florida and New York, supra note 8, at 589. See
also, Rosenthal, supra note 23, at Al.
59. Geoffrey Cowley et al., Tuberculosis: A Deadly Return, NEWSWEEK, March 16,
1992, at 53.
60. Tuberculosis in the New York City Criminal Justice System: Hearings Before the
Joint Assembly Committees on Correction and Health, 214th Gen. Assembly, 2d Reg. Sess.
(N.Y. 1992) [hereinafter Hearings] (testimony of James Neal, M.D.). "The 250,000 peo-
ple who are arrested and the 120,000 people who move through the City's correctional
system each year are among the poorest and sickest New Yorkers." Id.
61. Id. "The demographics and health indicators of this population, coupled with
environmental factors in the criminal justice system such as crowding, inadequate venti-
lation, constant movement and mixing of individuals, create conditions conducive to the
transmission of tuberculosis." Id. See also, Hans Abeles, et al., The Large City Prison -
A Reservoir of Tuberculosis, 101 AM. REV. RESPIRATORY DISEASE 706 (1970); Braun,
supra note 1.
62. REPORT ON TB IN THE CRIMINAL JUSTICE SYSTEM, supra note I at 11-12. See
also, Dixie Snider, Jr., M.D., M.P.H. and Mary Hutton R.N., M.P.H., Tuberculosis in
Correctional Institutions, 261 JAMA 436, 436-37 (1989); William Stead, M.D., Unde-
tected Tuberculosis in Prison Source of Infection for Community at Large, 240 JAMA
2544, 2544-47 (1978); NANCY MAHON, AIDS IN PRISON PROJECT, THE CORREC-
TIONAL ASs'N OF NEW YORK, DEVELOPING A SYSTEM FOR TB PREVENTION AND
CARE IN NEW YORK CITY (September 1992) (unpublished manuscript on file with
author).
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30,000 people entered the New York State prison system by the end of
1992.63 According to population statistics, 4,500 are HIV positive;
28%, or 1,260 inmates, of those are TB-infected.64 Eight percent of
those infected with TB will become contagious with active TB during
the next year. 65 Five thousand inmates at the New York Department
of Correctional Services (DOCS) are currently taking TB drugs
(INH) as a prophylaxis. 6
Inmates coming into the DOCS system are given an initial screen-
ing for latent TB infection. Twenty eight percent of the inmates in
reception test positive for latent TB infection. 67 The TB bacilli in-
fecting these inmates could continue to remain dormant or start to
multiply and convert into active, contagious TB disease in a matter of
weeks or months. There are no screening tests available to detect this
conversion. The active, contagious, TB disease will go unnoticed un-
til symptoms develop that lead the inmate to sick call.68 If the inmate
has HIV infection the symptoms may be confused with the onset of
HIV symptomatic illness, masking the TB disease and making diag-
nosis difficult.
DOCS has been experiencing a major crisis in the provision of
health care to HIV-infected prisoners. 69 AIDS is the leading cause of
death in New York -State correctional facilities. 70  The New York
State prison system has the highest caseload of persons with AIDS in
the United States. 7 ' There are currently estimated to be approxi-
mately 8000 prisoners in the New York State prison system who are
HIV-infected. 72 Early studies found that; "[s]tatistically, people in-




67. Interview with Robert Greifinger, supra note 13.
68. Id.
69. See REPORT ON TB IN THE CRIMINAL JUSTICE SYSTEM, supra note 1. See also
NYC BAR ASS'N AIDS REPORT, supra note 18, at 192-223. Vega v. Sielaff, No. 92 Civ.
6475, 1992 U.S. Dist. LEXIS 5249 (S.D.N.Y. Apr. 22, 1992) (concerning inadequate
medical care delivery to city jail inmates); Grubbs v. Brown, No. 92 Civ. 2132 (S.D.N.Y.)
(concerning medically inadequate conditions of confinement in court pens, pre-arraign-
ment holding areas and precinct pens); Inmates of New York State with H.I.V. v.
Cuomo, No. 90-CV-252, 1992 U.S. Dist. LEXIS 18797 (N.D.N.Y. Nov. 27, 1992); Cun-
ningham v. Coughlin, No. 92 Civ. 0579 (N.D.N.Y.) (similar class action law suits involv-
ing New York State prison inmates).
70. NEW YORK STATE COMMISSION OF CORRECTION, ACQUIRED IMMUNE DEFI-
CIENCY SYNDROME: A DEMOGRAPHIC PROFILE OF NEW YORK STATE INMATE MOR-
TALITIES 34 (3d ed. 1988).
71. THE CORRECTIONAL ASSOCIATION OF NEW YORK, AIDS IN PRISON FACT
SHEET (1991).
72. Interview with Robert Greifinger, supra note 13. The 8,000 figure was not arrived
480 [Vol. XX
RESERVOIRS OF TB DISEASE
fected with the AIDS virus who are incarcerated will live only half as
long as those in the general population."73 The death rate for inmates
living with HIV was 37.7 per 10,000 in 1987 and 37.3 per 10,000 in
1988 and declined to 26 per 10,000 in 1989 following the widespread
use of Zidovudine, a drug prescribed for HIV treatment and prophy-
laxis.74 The recent jump in mortality rates to 35.4 per 10,000 in 1991
is presumed to be caused by the short-lived protective effect of
Zidovudine and the outbreak of MDR TB among HIV-infected
inmates.75
The Department of Correctional Services is forced to deal with TB
and HIV epidemics in the inmate population in houses. The DOCS
inmate population has experienced a 900% increase in active tubercu-
losis over the past decade, including a recent outbreak of multiple
drug-resistant TB.76 The medical problems are multiplying exponen-
tially because the number of inmates in the system continues to in-
crease as concentrated numbers of HIV-infected inmates remain
undiagnosed for TB infection and/or active TB disease.77
The transmission of tuberculosis to persons with HIV infection is of
particular concern because they are at high risk of developing active
tuberculosis. 78  TB is difficult to detect in persons with compromised
immune systems, and it is those same people who are at the highest
risk to contract and spread TB.79 Tragically, the people who are most
at by identifying and counting each inmate who is HIV-infected, but by doing anonymous
blood testing on a sample of individuals in the prison system and then performing a
statistical analysis and projection for the prison population as a whole.
73. People v. Jimmie E., N.Y. L.J., April 4, 1991 at 21 (Sup. Ct. N.Y. County)
(White, J.).
74. Robert Greifinger, M.D., Tuberculosis Behind Bars, reprinted in AM. SOC'Y L. &
MED. ET AL., THE DUAL EPIDEMICS OF TUBERCULOSIS AND AIDS: HEALTH CARE
POLICY, PROFESSIONAL PRACTICE, LAW AND ETHICS 184-85 (Conference for World
AIDS Day, Dec. 4-5, 1992) (on file with author).
75. Id.
76. Letter from Sue Kelly, Executive Deputy Director, Office of Public Health, State
of New York Department of Health, to Commissioner Thomas A. Coughlin III, New
York State Department of Correctional Services (November 14, 1991) (on file with au-
thor). "The rate of TB among inmates has increased dramatically, rising almost 900 per-
cent, from 15 per 100,000 in 1976-78 to greater than 130 per 100,000 in 1988-91. Over 25
percent of incoming inmates are infected with TB based on significant skin test reactiv-
ity." Id. See also Elisabeth Rosenthal, HIV Infection Foiling the Tests That Detect Deadly
TB Germs, N.Y. TIMES, December 10, 1991, at Al.
77. Letter from Sue Kelly to Thomas Coughlin III, supra note 76, at 2.
78. Id. "The HIV epidemic has profound impact on the development of TB, and on
TB control efforts, in and out of correctional facilities. This is because co-infection with
TB and HIV increases the likelihood of developing TB disease dramatically; one estimate
is that every year, one of every ten people co-infected will develop active TB." Id. See also
Preventing TB in Health-Care Settings, supra note 24.
79. Daley, supra note 6, at 231.
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at risk are the hardest to protect.80 The large number of HIV-infected
inmates in prison, the difficulties of diagnosis and treatment, and the
poorly ventilated physical plants create a high likelihood of continued
and worsening outbreaks of TB and MDR TB in prison.
G. Problems in Treating Inmates in Jails and Prisons
The city and state prison systems are medically ill-equipped to han-
dle the increasing number of sick inmates. Both systems are unable to
implement adequate protocols to detect, treat and control diseases
among prisoners.8 1 Even given the best of medical leadership and in-
tentions, the very nature of prison systems with the primary emphasis
on security mitigates against providing optimal medical attention to
both the HIV and TB/MDR TB epidemics.8 2 The emphasis on secur-
ity translates into periodic, irregular transfers of inmates and lack of
cooperation by security staff in implementing medical follow-up.
Treatment of inmates with TB who are no longer contagious but must
continue to take their medications may be interrupted by transfer to
another institution or release from custody before drug therapy is
completed. In addition, inmates released from jail may not be ade-
quately supplied with medication and may not be linked with a com-
munity-based treatment facility. 83
The inmates' distrust of prison health care providers also detracts
from the ability of the prison system to adequately treat them.8 4
80. Snider and Roper, supra note 36; See Peter Barnes et al., Tuberculosis in Patients
with Human Immunodeficiency Virus Infection, 324 NEW ENG. J. MED. 23 (1991). See
also, MDR TB Among HIV Infected in Florida and New York, supra note 8.
81. REPORT ON TB IN THE CRIMINAL JUSTICE SYSTEM, supra note 1. See also NYC
BAR ASS'N AIDS REPORT, supra note 18, at 192-223; Stead, supra note 62; Mahon, supra
note 62; Vega v. Sielaff, No. 92 Civ. 6475, 1992 U.S. Dist. LEXIS 5249 (S.D.N.Y. Apr.
22, 1992) (concerning inadequate medical care delivery to city jail inmates); Grubbs v.
Brown, No. 92 Civ. 2132 (S.D.N.Y.) (concerning medically inadequate conditions of con-
finement in court pens, pre-arraignment holding areas and precinct pens); Inmates of
New York State with H.I.V. v. Cuomo, No. 90-CV-252, 1992 U.S. Dist. LEXIS 18797
(N.D.N.Y. Nov. 27, 1992); Cunningham v. Coughlin, No. 92 Civ. 0579
(N.D.N.Y.)(similar class action law suits involving New York State prison inmates).
82. GAUNAY, MDR TB OUTBREAK REPORT AMONG INMATES, supra note 7. Ac-
cording to this report, inmate specimens submitted for culture "required an average of
21.5 days to report, one required 113 days and four cases an average 3.6 months .... At
present, (July 1992), the laboratory capacity available for rapid confirmation of tubercu-
losis culture results to prison-based clinicians is grossly inadequate to diagnose tuberculo-
sis within time frames necessary to limit transmission and to identify drug resistant
strains." Id. at iv. See also, supra note 81.
83. Braun, supra note 1, at 397. See also REPORT ON TB IN THE CRIMINAL JUSTICE
SYSTEM, supra note 1, at 44-45.
84. Susan E. Shepard, DEP'T OF INVESTIGATION, CITY OF NEW YORK, AN INVESTI-
GATION INTO THE PROCESS OF ADMITTING INMATES AT THE MANHATrAN DETEN-
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There are a myriad of other problems associated with the delivery of
medical services in prison. First, the prison system is confronted with
fiscal constraints and the physical plants used for housing and medical
facilities are antiquated. Additionally, there is a reluctance on the
part of community health-care providers to care for inmates, who are
often viewed as "pariahs." Finally, inmates are faced with a public
health infrastructure that is unable to deliver timely surveillance, con-
tract tracing, and continuity of care upon discharge.8"
Protocols for TB surveillance in correctional settings have been de-
veloped by the Centers for Disease Control, the New York City and
State Health Departments and the New York State Department of
Correctional Services. 6 Even if these protocols are implemented to
TION COMPLEX: VIOLATIONS OF DEPARTMENT OF CORRECTION DIRECTIVES AND
FEDERAL COURT ORDERS (1992). Although the investigation concerned whether or not
orders were followed concerning admitting detainees within 24 hours, the results indi-
cated that repeatedly inmates were housed in general population without first receiving
the mandated medical screenings. Id at 24.
See also, REPORT ON TB IN THE CRIMINAL JUSTICE SYSTEM, supra note 1, at Appen-
dix "A" (Letter from Harold Appel, M.D. to the Task Force) (Dr. Appel has been a
prison health doctor for 18 years).
[Aiccess to care is the inmates' biggest health problem. This situation is a result
of the Department of Correction personnel sometimes acting as a resentful or
reluctant gatekeeper to health care .... What specifically am I talking about?
I'm talking about the PPDs not being read because the inmate 'can't be located'
or are encouraged to 'refuse' treatment. The reading of the PPDs is clearly the
heart of the problem but I'm also talking about missed medication because the
inmate 'didn't respond' or because they went to court. I'm talking about delays
in getting lab and x-ray results, about lost medical records, about specialty
clinic appointments delayed for months and then, on the long awaited date, the
inmate is brought too late or to the wrong place or after being awakened early
in the morning and waiting all day in a holding pen are encouraged to 'refuse'
treatment so they can return 'home' before late at night. I'm talking about
inmates really [emphasis in original] refusing treatment because of these exper-
iences and their perception of getting second class treatment at the city hospi-
tals. I'm also talking about a demoralized staff working in a hostile environment
who are blamed for these problems not of their making, who work in an atmos-
phere conducive to contagion [emphasis added] and who are often viewed with
suspicion by the people they are trying to help because they are seen as a part of
this faulty system. What I am saying is that it would be great if experts develop
protocols for treatment and plans for healthier inmate housing and clinic areas,
for aftercare programs, for epidemiologic surveys and the like but unless the
correctional health care system is made to work properly, the incidence of tu-
berculosis will continue to rise.
Id.
85. Vega v. Sielaff, No. 92 Civ. 6475, 1992 U.S. Dist. LEXIS 5249, (S.D.N.Y. Apr.
22, 1992); Inmates of New York State with H.I.V. v. Cuomo, No. 90-CV-252, (S.D.N.Y.
Nov. 27, 1992); Cunningham v. Coughlin, No. 92 Civ. 0579 (N.D.N.Y.); Grubbs v.
Brown, No. 92 Civ. 2132 (S.D.N.Y.); See also, GAUNAY, MDR TB OUTBREAK REPORT
AMONG INMATES, supra note 7; Mahon, supra note 81.
86. CONTROL OF TB IN CORRECTIONAL FACILITIES, supra note 5; Letter from Sue
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the letter, the risks of transmission of TB and MDR TB remain
alarmingly high. Anyone who is HIV-immunosuppressed is at great
risk of infecting others, of being infected with TB and the multi-drug
resistant strains of TB, or both.87 This is due to a number of factors,
including the large and dynamic population of unknown HIV-in-
fected inmates; the difficulty in rapid diagnosis of TB disease among
this population; ,and the cost limitations and physical limitations of
definitive serology and pre-diagnostic isolation.
III. Legal Overview and Strategies for Sentencing HIV-Infected
Defendants-
The structure of the New York State sentencing law does not take
into account the ramifications of the severe medical crisis confronting
the criminal justice system by the convergence of the HIV and TB
epidemics in the correctional system. The ability of the system to
fairly evaluate individual cases and judiciously use limited prison re-
sources is hampered by certain statutory restrictions. Mandatory sen-
tencing, as well as a complete statutory ban on judicial modification of
sentences once a term of incarceration has begun severely limits the
exercise of judicial discretion. Furthermore, statutory restrictions on
plea bargaining after indictment limit the prosecutor's discretion to
offer lesser pleas in recognition of defendant's medical circumstances.
A. The Mandatory Sentencing Provisions and Restrictions on
Plea Bargaining
Article 70 of the New York State Penal Law provides for
mandatory imprisonment for a number of crimes and classes of of-
fenders."8 New York Criminal Procedure Law (CPL) section
220.10(5) contains restrictions on plea bargaining after indictment
Kelly to Thomas Coughlin III, supra note 76; REPORT ON TB IN THE CRIMINAL JUS-
TICE SYSTEM, supra note 1.
87. MDR TB Among HIV Infected in Florida and New York, supra note 8.
At least two categories of factors may have contributed to these [MDR TB]
outbreaks. First, diagnosis of TB in HIV-infected patients was delayed, in may
cases, because of unusual clinical and radiographic characteristics, and recogni-
tion of drug resistance was delayed because of the lengthy time required for
laboratory identification, confirmation, and reporting of drug-resistance pat-
terns. Until M. tuberculosis drug resistance was identified as a problem and the
pattern of resistance known, no reliably effective therapeutic regimens could be
prescribed. Thus, treatment regimens had to be adjusted empirically when pa-
tients failed to respond, and patients sometimes remained infectious for pro-
longed periods.
Id. at 589.
88. N.Y. PENAL LAW § 70 (McKinney 1987).
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which limit the discretion of the prosecutor to offer pleas to lesser
offenses in many circumstances.8 9 These two provisions work to-
gether to severely limit the ability of judges, prosecutors, and defense
attorneys to fashion appropriate dispositions in many cases involving
HIV-debilitated and TB-vulnerable defendants.
Judges and prosecutors need the discretion to divert terminally ill
defendants out of the prison system in cases where sending the de-
fendant to jail exposes him/her to a significant risk of contracting a
disease that would hasten his/her already imminent death. Public
health considerations as well as an interest in maximizing the re-
sources of the criminal justice system argue for the availability of
nonincarcerative sentences in such circumstances.
The public safety is better served by not sending HIV-infected TB
sensitive defendants into an environment where their chances of
catching and spreading TB are significantly increased. 90 The public
health consequences. of fueling the TB epidemic in the prisons are
awesomely frightening. The economic cost to the public of treating
an inmate is astronomical. 91 In addition, litigation costs could be
minimized in appropriate cases if early nonincarcerative dispositions
were available, saving the limited court and prison resources of the
criminal justice system for defendants who are more likely to pose a
future threat to society.
The arguments for allowing pleas to nonincarcerative sentences in
cases that now require a prison term are most compelling when the
crimes charged are nonviolent, victimless, or involve compelling miti-
gating circumstances. Street level drug offenses are a prime example
of cases that would benefit from case-by-case scrutiny by the judici-
ary. The interaction of the felony drug laws and the second felony
offender laws create many situations where a judge's hands are tied
and the only legal sentence is an indeterminate prison sentence.92 It
89. N.Y. CRIM. PROC. LAW § 220.10(5) (McKinney 1992).
90. See generally Braun, supra note 1; Abeles, supra note 61; NEW YORK STATE
COMMISSION OF CORRECTION, ACQUIRED IMMUNE DEFICIENCY SYNDROME: A DEMO-
GRAPHIC PROFILE OF NEW YORK STATE INMATE MORTALITIES, supra note 70 and
accompanying text.
91. See supra note 13 and accompanying text.
92. Under Article 220 of the Penal Law, possession of any amount of any controlled
substance with the intent to sell it is a Class D felony carrying a mandatory minimum
sentence of two to four years for any second felony offender. Possession of any amount of
a narcotic drug with the intent to sell it is a Class B felony carrying a mandatory mini-
mum sentence of four and one-half years to nine years for any second felony offender.
Possession of any mixture of one-eighth ounce or more containing a narcotic drug is a
Class C felony carrying a mandatory minimum sentence of three years to six years re-
gardless of intent. The laws regarding street level drug sales are similarly classified. The
sale of any narcotic drug regardless of amount is aClass B felony carrying a minimum
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comes as no surprise then that 60% to 70% of New York State pris-
oners (34,500 to 40,250 inmates) have a history of drug abuse and
about 60% of offenders sent to state prison in 1990 were convicted of
nonviolent crimes.9 a Ironically, it is the drug offenders who are most
likely to be HIV-infected and most vulnerable to TB infection.
The New York State Bar Association has recommended an amend-
ment to the Criminal Procedure Law that would give judges greatly
needed flexibility in plea bargaining. 94 The proposed amendment
adds a new subsection 5(h) to Criminal Procedure Law section 220.10
that reads:
Notwithstanding the above provisions, the court, upon the consent
of the defense and district attorney, and upon a finding that the
defendant is suffering from a terminal condition, disease or syn-
drome and to be so debilitated or incapacitated as to create a rea-
sonable probability that he or she is physically incapable of
presenting any danger to society, and upon a finding that the fur-
therance of justice so requires, may accept a plea of guilty to any
lesser included offense of any count of the indictment, to satisfy the
entire indictment. In making such determination, the court must
consider the factors listed in Criminal Procedure Law § 210.40
(1)(a-j) (McKinney 1992) (governing dismissals in the interest of
justice).95
At least this amendment would allow the parties to fashion more ap-
propriate dispositions for terminally ill defendants. But, given the
susceptibility of any HIV-immunosuppressed defendant to TB dis-
ease, an alternative that allows consideration of the prospective life
threatening danger of an incarcerative sentence may be warranted. 96
Criminal Procedure Law section 430.10 prohibits a judge from
changing, interrupting, or suspending a sentence of imprisonment af-
ter service of the sentence has begun. 97 This provision can be devas-
tating to an inmate whose medical condition was unknown at the time
term of incarceration of four and one half years to nine years. N.Y. PEN LAW § 220.39
(McKinney 1992). This would apply equally to an HIV-infected drug addict selling as
little as one grain of heroin to an undercover officer to support his own habit as it would
to a higher level dealer selling a significantly larger amount of narcotics. Interestingly,
the addict/seller of one grain of heroin who has a prior felony conviction of any kind is
also likely to be subjected to a more stringent sentence than the perpetrator of a violent
felony offense who has no prior felony convictions.
93. THE CORRECTIONAL ASSOCIATION OF NEW YORK, PRISONER PROFILE (1991).
94. NEW YORK STATE BAR Ass'N COMMITTEE ON AIDS AND THE LAW, REPORT
ON AIDS AND THE LAW (1992).
95. Id. at 32.
96. Id. This could be accomplished by changing the word "and" in the Bar Associa-
tion's proposed amendment to "or".
97. N.Y. CRIM. PROC. LAW § 430.10 (McKinney 1992).
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of sentence or significantly deteriorated during service of the sentence.
Again the sentencing judge's hands are tied even if he/she would have
sentenced the defendant differently had the defendant's medical con-
dition been known at the time of sentence.
The pointlessness and poignancy of people dying in prison are not
the only concerns. The vast increases in the number of desperately ill
inmates puts tremendous pressure on jail and prison medical facilities,
and presents the taxpayer with a far more burdensome health care bill
given the increased cost of medical treatment in a correctional setting.
B. What Alternatives Do Practitioners And Judges Have Now?
New York State law does leave some limited options for diversion
of terminally ill/HIV-infected individuals out of the jail and prison
system. All of the options are discretionary and have thus far been
used sparingly. But with more widespread recognition of the danger
of the TB epidemic and the emergence of the more virulent strands of
MDR TB, there is greater recognition of the necessity of alternatives
to incarceration for terminally ill defendants. Alternatives to incar-
ceration serve both the public policy interest in curbing the spread of
the TB epidemic and a humanitarian interest in not inflicting unneces-
sary pain and suffering on an already ill defendant.
1. Pre-Sentence
Obviously, in cases where there are no restrictions on plea bargain-
ing, counsel should attempt to plea bargain with the district attorney
to avoid a jail or prison sentence. In cases where CPL section
220.10(5) would limit plea bargaining after indictment counsel can try
to work out an acceptable disposition by agreeing to waive indictment
under Article 195 of the Criminal Procedure Law. 98
In cases where plea bargaining to a nonincarcerative sentence is not
possible, either because of statutory restrictions or the reluctance of
the local district attorney, counsel should consider filing a motion to
dismiss in furtherance of justice (Clayton Motion) pursuant to CPL
section 210.40.9' If that motion is unsuccessful, delay of sentence is a
possibility under CPL section 380.30(l).1°
2. Motions to Dismiss in Furtherance of Justice
Currently, the motion to dismiss in furtherance of justice may be
98. N.Y. CRIM. PROC. LAW § 195 (McKinney 1992).
99. People v. Clayton, 342 N.Y.S.2d 106 (App. Div. 1973); See also N.Y. CRIM.
PROC. LAW § 210.40 (McKinney 1992).
100. N.Y. CRIM. PROC. LAW § 380.30(1) (McKinney 1983).
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the New York defense attorney's best approach for avoiding the im-
position of mandatory prison sentences. The all or nothing nature of
the Clayton motion makes it a less than perfect solution to the di-
lemma posed by many cases, but it at least offers judges the opportu-
nity to consider the particular facts and circumstances of a case, and,
where appropriate, divert the case from the criminal justice system. 'l
The Clayton motion allows a judge to dismiss an indictment
in the furtherance of justice ... even though there may be no basis
for dismissal as a matter of law ... [when] such dismissal is re-
quired as a matter of judicial discretion by the'existence of some
compelling factor, consideration or ,circumstance clearly demon-
strating that conviction or prosecution of the defendant upon such
indictment or count would constitute or result in injustice.' 0 2
The statute lists the following ten factors for a judge to consider when
determining a Clayton motion:
a. the seriousness and circumstances of the offense;
b. the extent of harm caused by the offense;
c. the evidence of guilt, whether admissible or inadmissible at
trial;
d. the history, character and condition of the defendant;
e. any exceptionally serious misconduct of law enforcement per-
sonnel in the investigation, arrest and prosecution of the
defendant;
f. the purpose and effect of imposing upon the defendant a sen-
tence authorized for the offense;
g. the impact of a dismissal upon the confidence of the public in
the criminal justice system;
h. the impact of a dismissal on the safety or welfare of the
community;
i. where the court deems it' appropriate, the attitude of the com-
plainant or victim with respect to the motion;
j. any other relevant fact indicating that a judgment of conviction
would serve no useful purpose.' 3
A Clayton motion offers the judiciary the opportunity to consider
"the needs of both the defendant and society . . . on an ad hoc ba-
101. N.Y. CRIM. PRoc. LAW § 210.40 allows a judge to dismiss an "indictment or any
count thereof' (emphasis added) in furtherance of justice. Therefore, the judge could
dismiss only the counts that require the imposition of prison terms and leave those counts
that would allow her to sentence the defendant to probation or impose conditions, rather
than dismissing the entire indictment.
102. N.Y. CRIM. PROC. LAW § 210.40(1) (McKinney 1992).
103. N.Y. CRIM. PROC. § 210.40 (McKinney 1992).
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sis."' 4 Many New York judges have been receptive to Clayton mo-
tions brought on behalf of defendants who are. suffering with
advanced cases of AIDS or AIDS-Related Complex (ARC). Obvi-
ously, the seriousness and circumstances of the offense and the de-
fendant's criminal history may weigh against dismissal. Courts have
dismissed serious felony charges brought against recidivists, but only
in cases where the defendant's death was imminent. 0 5
Courts have also begun to seriously consider Clayton motions even
when the defendant has not progressed from HIV disease to AIDS or
ARC."° One court, in dismissing felony drug charges in the further-
ance of justice, explicitly recognized the reality that an economically
deprived, homeless defendant with HIV illness is effectively termi-
nal.'0 7 The situation that now faces defendants with AIDS or HIV
infection in prison makes an even more compelling motion for dismis-
sal in furtherance of justice. Certainly the argument can be made that
an immune-suppressed defendant stands a high risk of contracting
MDR TB in prison and that an' immune-suppressed person with
MDR TB is effectively terminal.
Many of the statutory factors for determining a Clayton motion are
applicable and arguably compelling in every case involving a defend-
ant with a severely compromised immune system given the presence
of a TB epidemic in the prisons. The "history, character and condi-
tion of the defendant" allows a judge to consider the defendant's med-
ical history and condition. Counsel should attach the defendant's
medical records to the motion papers, and where possible, offer the
court evidence (either in the form of expert testimony at a hearing or
letters or affidavits attached to the motion papers) of the severity of
the defendant's condition. 08
"The purpose and effect of imposing upon the defendant a sentence
authorized for the offense" is also relevant in virtually all cases involv-
ing immune-compromised defendants. There is arguably little pur-
pose in having a terminally ill defendant serve a prison sentence.
104. People v. Suarez, N.Y. L.J. February 1, 1991, at 21, (Sup. Ct. N.Y. County)
(Crane, J.).
105. People v. Camargo, 516 N.Y.S.2d 1004 (Sup. Ct. Bronx County 1986); People v.
Roman, N.Y. L.J., October 5, 1990, at 21 (Sup. Ct. Bronx County) (Bamberger, J.);
People v. Scruggs, N.Y. L.J., July 20, 1987, at 18 (Sup. Ct. Kings County) (Meyerson, J.);
People v. Williams, N.Y. L.J., September 18, 1987, at .13 (Sup. Ct. N.Y. County) (Levit-
tan, J.).
106. Suarez, N.Y. L.J., February 1, 1991, at 21; People v. Gray, N.Y. L.J., March 15,
1991, at 21 (Sup. Ct. Kings County) (Miller, J.).
107. Suarez, N.Y. L.J., February 1, 1991, at 21.
108. Counsel should take precautions to protect the defendant's rights to confidential-
ity pursuant to N.Y. Pun. HEALTH LAW §§ 2780-2787. (McKinney Supp. 1993).
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Judges have referred to the imposition of a prison sentence on a termi-
nally ill defendant as "an exercise in futility ' ' 09 and "both wanting
and cruel."' 10 Judges have also recognized that the defendant's illness
is a significant punishment in itself concluding that "[n]o sentence...
could compare with the severity of the many diseases being painfully
and fatally suffered by ... [the]... defendant.""'1  Given the current
medical realities, counsel can also argue that the effects of having the
defendant serve time for the offense will be devastating to the defend-
ant and excessively cruel in relation to the crime. Counsel can make a
compelling case for dismissal by offering evidence relating to the prev-
alence of TB in prisons and the dangerous interaction of AIDS, HIV
infection and TB disease.
"The impact of a dismissal upon the confidence of the public in the
criminal justice system" can also argue favorably for dismissal in
these cases. Given the economic realities of the 1990s the public will
arguably appreciate a criminal justice system that examines each indi-
vidual case before committing the system's limited resources. In
granting a Clayton dismissal, one judge noted:
The indictment's dismissal will have a beneficial effect upon the
criminal justice system. The prison health services [sic] resources
will be available. A dismissal will end a proceeding which proba-
bly will not go to trial. And, the prosecution will be able to devote
attention to the large volume of serious and violent felony cases." 2
More importantly, increased public awareness of the harsh realities
of AIDS, HIV, and TB should contribute to the public's understand-
ing of the need for more compassionate treatment of seriously ill de-
fendants. In dismissing a felony case against a terminally ill
defendant one judge wrote:
[1]f the moral fabric of our society is perceived to be so thin or
taught [sic] as to be rent by a dismissal of these charges under the
circumstances presented, then this court is at a loss to explain the
cynicism and collective mean-spiritedness which the foregoing
would seem to imply.'
Ultimately, "[iun the eyes of the public, the criminal justice system
109. Camargo, 516 N.Y.S.2d at 1006.
110. People v. Ortiz, N.Y. L.J., February 16, 1990, at 21 (Sup. Ct. Bronx County)
(Massaro, J.).
111. Camargo, 516 N.Y.S.2d at 1006-7.
112. People v. Gamble, N.Y. L.J., September 30, 1991, at 21 (Sup. Ct. Bronx County)
(Brandveen, J.); See also, People v. Roman, N.Y. L.J., October 5, 1990, at 25, (Sup. Ct.
Bronx County) (Bamberger, J.).
113. People v. Jacobs, N.Y. L.J., Aug. 22, 1986, at 14 (Sup. Ct. Richmond County).
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can only be enhanced where knowledge that reason and compassion
not pointless prosecution or punishment guide responsible judicial de-
cision making."' 1 4
The court's consideration of "[t]he impact of a dismissal on the
safety or welfare of the community" in these cases also favors dismis-
sal. It has often been argued that many people who have AIDS are in
too poor health to pose a threat to the safety and welfare of the com-
munity. A broader case can be made by delineating the public health
benefit of limiting the exposure of highly susceptible, severely im-
mune-compromised individuals to TB and MDR TB and thereby lim-
iting the further spread of the TB epidemic. The safety and welfare of
the community is not enhanced by the compulsory dumping of HIV-
infected defendants into the reservoir of TB infection in our prisons
and jails. Anyone who is immune-compromised is more prone to
catch TB and because they are more difficult to diagnose, screen and
treat they are also more likely to spread the infection to others. Given
the constant circulation of people between the community and the
prison system, an epidemic in the prisons will inevitably lead to an
epidemic in the community."1 5
Finally, CPL section 210.40 allows a judge to consider "any other
relevant fact indicating that a judgment of conviction would serve no
useful purpose." This catch-all often encompasses many of the argu-
ments already advanced. If under the circumstances of the case there
would be no particular deterrent effect and no need for isolation of the
defendant then a conviction would serve no useful purpose. As one
judge noted in dismissing a case "[t]o ask for 'revenge'. . is
perverse."1 16
Because the Clayton motion is entirely within the discretion of the
trial judge, denial will not often offer a viable appellate issue. How-
ever, given the susceptibility of immune-compromised defendants to
TB and the virtual impossibility of protecting an inmate from expo-
sure in prison, the motion is well worth pressing, particularly for a
defendant who is charged with a nonviolent offense.
3. Delay of Sentence
Practitioners have started to request delay of sentence in cases
where the defendant's motion for Clayton relief has been denied and
114. Ortiz, N.Y. L.J., Feb. 16, 1990, at 21; see also, People v. Gonzalez, N.Y. L.J.,
March 28, 1988, at 54 (Sup. Ct. Queens County) (Clabby, J.).
115. REPORT ON TB IN THE CRIMINAL JUSTICE SYSTEM, supra note 1. See also
MAHON, supra note 62.
116. Roman, N.Y. L.J., Oct. 5, 1990, at 21 (Sup. Ct. Bronx County) (Bamberger, J.).
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he/she faces mandatory incarceration upon sentence. CPL section
380.30 (1) provides that "[s]entence must be pronounced without un-
reasonable delay." Some judges are now accepting guilty pleas but
continuing the defendants on bail or parole and adjourning the sen-
tence at the defense's request. This alternative is supported by the
recognition that the defendant is too ill to commit further crimes and
incarceration would serve no useful purpose. I 7 This is often a more
attractive option to the judges and district attorneys because, unlike
an outright dismissal, it allows the court to retain jurisdiction over the
defendant.
4. Post-incarcerative sentence
After an incarcerative sentence has been imposed, the alternatives
are more limited. The New York State legislature enacted a medical
parole law in March 1992 which permits terminally ill prisoners iwho
have not been convicted of the most serious crimes, and who no
longer present a danger to society to be paroled prior to the expiration
of their minimumsentence. 118 According to the Correctional Associ-
ation of New York, which has been monitoring the implementation of,
the law, the anticipated humanitarian purposes and medical cost-sav-
ing benefits have not been realized thus far:
Sadly, the law's promise has not been fulfilled To date, [October
16, 1992] only four prisoners have been released on medical parole
while over 150 prisoners have died of AIDS in New York State
prisons since the law's passage. No prisoners have been released
who needed home care. Correctional officials conservatively esti-
mate that 50 to 80 applications are currently pending. Although
the processing of each application is time consuming, the law does
not provide funding for additional staff for Department of Correc-
tional Services (DOCS) or for Division of Parole (Parole), the two
agencies administering the law." 9
The legislature could alleviate the problems associated with incarcer-
ating HIV-infected offenders by reconsidering the mandatory sentenc-
ing laws and by lessening plea bargaining restrictions in the interest of
justice.
117. Letter from Laura Held, Assigned Counsel Plan Administrator for the First De-
partment to members of the Appellate Division - First Department 18-B Panel (Octo-
ber 6, 1992) (on file with author).
118. N. Y. EXEC. LAW § 259-r (McKinney Supp. 1993).
119. NANCY MAHON, AIDS IN PRISON PROJECT, THE CORRECTIONAL ASSOCIATION
oF NEW YORK, UPDATE AND RECOMMENDATIONS ON THE IMPLEMENTATION OF
MEDICAL PAROLE (1992).
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C. Is An Eighth Amendment Claim Of Cruel And Unusual
Punishment Justified In These Circumstances?
In Solem v. Helm, the Supreme Court announced that no sentence
is shielded from constitutional challenge, 120 and that even "a single
day in prison may be unconstitutional in some circumstances."1 2 1
Given the current conditions in the correctional facilities, the severely
heightened susceptibility of HIV-infected individuals to contracting
TB, or worse yet, MDR TB and the rapidity with which MDR TB
infection can kill people with compromised immune systems, can the
argument be made that sentencing a person with a severely compro-
mised immune system to a term of incarceration in a correctional in-
stitution, where exposure to TB and or MDR TB is likely, amounts to
cruel and unusual punishment under the Eighth Amendment?
In Solem, the Supreme Court held that prison sentences are subject
to a proportionality analysis that examines (1) the gravity of the of-
fense and the harshness of the penalty, (2) compares the sentences
imposed on other criminals in the same jurisdiction, and, (3) may
compare the sentences imposed for the commission of the same crime
in other jurisdictions.122 However, after the Supreme Court's ruling
in Harmelin v. Michigan, 123 in the very least Solem has been severely
limited. The five-member majority agreed to either overrule or se-
verely narrow the proportionality of punishment analysis as applied
to noncapital criminal sentences.' 24 Justice Kennedy, in his concur-
ring opinion joined by two other Justices, altered the three-factor So-
lem test. The concurrence found that unless there is a threshold
finding of gross disproportionality between the crime committed and
the sentence, the second and third prongs of the Solem analysis
should not be used.' 25
Despite the ambiguity of the present state of Eighth Amendment
jurisprudence in the context of noncapital cases, it. is clear that the
standard for a finding of cruel and unusual punishment based on an
excessive sentence is high. The sentence must be "grossly dispropor-
tionate to the severity of the crime." 126 Successful constitutional chal-
120. Solem v. Helm, 463 U.S. 277 (1983).
121. Id. at 290.
122. Id. at 290-291.
123. Harmelin, 111 S. Ct. 2680 (1991).
124. Id at 2686, 2702.
125. Id. at 2707.
126. Id. at 2707 (Kennedy, J., concurring); Rummel v. Estelle, 445 U.S. 263, 271
(1989).
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lenges to sentences other than capital sentences are rare. 27 Absent
"extreme facts"' 21 the courts are reluctant to invalidate what they re-
gard as the "legislative prerogative."'129  In New York, sentencing
an individual to an authorized sentence of imprisonment is ordinarily
not cruel and unusual punishment in the constitutional sense. 30
However, the New York courts have recognized that there may be
exceptional cases where a sentence within statutory limits constitutes
cruel and unusual punishment. '3'
The New York Court of Appeals has rejected constitutional chal-
lenges to mandatory sentences in drug cases reasoning that the
mandatory sentences under Article 70 of the Penal Law are not
grossly disproportionate to the offense nor do they "shock the con-
science of the community."'13 2 They have also held that "a defend-
ant's affliction with AIDS, in and of itself, is not an extraordinary
circumstance which would warrant interference with a sentence im-
posed within statutory guidelines."'' 3 3 Despite their reluctance to in-
terfere with legally imposed sentences, New York courts have
repeatedly recognized that there may be "exceptional circumstances"
or "rare cases" where the imposition of a legally-mandated sentence
would be constitutionally prohibited. 34  But, legally imposed
sentences must be regarded as "subhuman" not simply "harsh" to
constitute cruel and unusual punishment. 3 5
The medical consequences in prisons of the interaction of AIDS/
127. Harmelin, 111 S. Ct. at 2705 (Kennedy, J., concurring); Solem, 463 U.S. at 289-
90; (both cases quoting Rummel, 445 U.S. at 272).
128. Rummel, 445 U.S. at 273.
129. Id. at 273, 274.
130. People v. Jones, 350 N.E.2d 913 (N.Y. 1976)
131. Rummel v. Estelle, 445 U.S. 263 (1979); People v. Broadie, 332 N.E.2d 336 (N.Y.
1975), cert. denied 423 U.S. 950 (1975).
132. Broadie, 332 N.E.2d 336 (N.Y. 1975), cert. denied, 423 U.S. 950 (1975).
133. People v. Chrzanowski, 538 N.Y.S.2d 55 (App. Div. 1989) (citations omitted);
People v. Napolitano, 525 N.Y.S.2d 698 (App. Div. 1988); People v. Escobales, 551
N.Y.S.2d 757 (Sup. Ct. Bronx County 1990); see also, People v. Clark, 576 N.Y.S.2d
704,705 (App. Div. 1991).
134. People v. Jones, 350 N.E.2d 913 (N.Y. 1976) (the fact that co-defendants in drug
case got less time not exceptional circumstance); People v. Clark, 576 N.Y.S.2d 704
(App. Div. 1991) (HIV positive mother with two small children not the rare case where
legal sentence is constitutionally prohibited); People v. Rivera, 501 N.Y.S.2d 122 (App.
Div. 1986) (mandatory prison sentence is harsh but not the rare case where sentence is
constitutionally invalid); People v. Hooks, 467 N.Y.S.2d 8 (App. Div. 1983) (despite miti-
gating factors surrounding commission of the offense and the defendant's character and
background this is not the very rare case calling for judicial interference with the legisla-
tive prerogative); People v. Alvarez, 410 N.Y.S.2d 840, 845 (App. Div. 1978) (court re-
versing on other grounds noted grave doubts as to constitutionality of mandatory
sentence given defendant's lack of criminal history and minor participation in drug case).
135. Escobales, 551 N.Y.S.2d at 759.
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HIV infection and TB, and the presence of MDR TB in correctional
settings in New York, presents a new and much more compelling
medical crisis to the courts than the medical crisis presented by
AIDS/HIV infection alone. While courts have consistently held that
"[t]he fact that defendant is HIV-positive or suffers from AIDS is not
a sufficient reason to modify an otherwise lawful sentence of imprison-
ment," ' 36 they have never been confronted with the devastating con-
sequences of exposing immune-suppressed individuals to new, more
virulent strains of TB. Nor have courts confronted the prison sys-
tem's unique position as an unwitting breeding ground for TB, and
the correctional system's inability to protect the most medically vul-
nerable inmates from exposure.
Exposing a defendant to a significant risk of contracting a poten-
tially deadly disease is a harsh sentence - in some cases of extreme
immunodeficiency it may be tantamount to a death sentence involving
a "lingering" and painful death.' a3 In the capital context, the stricter
Harmelin analysis does not apply. The Supreme Court ruled in Coker
v. Georgia 138 that the Eighth Amendment bars punishments which
are excessive in relation to the crime. Where the punishment is
"nothing more than the purposeless and needless imposition of pain
and suffering," it violates the Eighth Amendment.1 39 An HIV-in-
fected offender who commits a nonviolent crime and is incarcerated in
a prison facility with a high prevalence of TB could be subject to a
"lingering death" that could be found excessive in relation to the
crime committed, and in violation of the Eighth Amendment.140 The
new medical realities applied to a nonviolent crime, or other mitigat-
ing circumstances, may present the extraordinary facts that would
merit reversal of an otherwise lawful prison sentence on Eighth
Amendment grounds.
IV. Conclusion
The convergence of the HIV and the tuberculosis epidemics among
criminal defendants presents a major crisis in the criminal justice sys-
tem and a challenge to everyone in the system to work together to
create humane, compassionate and just responses to the cruel and un-
136. Clark, 576 N.Y.S.2d at 705.
137. In re Kemmler, 136 U.S. 436, 447 (1890) (tortuous or lingering death unnecessa-
rily cruel and violative of the Eighth Amendment).
138. 433 U.S. 584, 592 (1977) (death sentence grossly disproportionate and excessive
punishment for crime of rape).
139. Id.
140. Coker, 463 U.S. at 592; In re Kremmel, 136 U.S. 436, 447 (1890).
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usual circumstances these two epidemics create. Often, justice is not
served by sentencing defendants, particularly nonviolent second fel-
ony offenders with compromised immune systems, to prison terms
where they face a grave risk of contracting multi-drug resistant
tuberculosis.
This Essay has discussed the specifics of both HIV and TB disease
in an attempt to convey the medical risks of contraction and the at-
tendant fatal consequences of MDR TB to defendants with HIV in-
fection. Readers, especially defense attorneys, prosecutors and judges
should use this knowledge to determine whether the criminal justice
system as it now operates is fair to defendants with HIV infection.
Where the system works injustice, practitioners can alter their case
strategy, prosecutors can change their policies, judges can alter their
rulings, and, finally, legislators can change laws. As a humane and
just society, we must think carefully before incarcerating medically
vulnerable defendants into a sea of disease.
